Acquisition focused on lead clinical-stage program ICT01 in acute myeloid leukemia, where data from the ongoing Phase I/II EVICTION trial showed high treatment response ICT01 has the potential to be a ...
Acquisition focused on lead clinical-stage program ICT01 in acute myeloid leukemia, where data from the ongoing Phase I/II EVICTION trial showed ...
Founded in 2016 by Jérémie Laurent at the Saint-Louis Hospital in Paris, a prestigious hub for leading cell therapy research, Astraveus is committed to revolutionizing the development and ...
Medicare beneficiaries with amyotrophic lateral sclerosis (ALS) were found to have more than 3 times the Medicare expenditures and beneficiary liability of the average Medicare beneficiary.
The global Clinical Analytics Market, valued at US$27.65 billion in 2024, stood at US$33.09 billion in 2025 and is projected to advance ...
In a sweeping expansion of its cancer drug portfolio, global biopharmaceutical powerhouse Ipsen SAS announced Wednesday that ...
Frontier Scientific Solutions is creating the nation’s first “scheduled service” flights for the pharmaceutical and ...
Aging populations and clearer U.S. drug pricing boost long-term pharma outlook. Leaders like Eli Lilly and Merck lead in ...
PE: What makes TrumpRx different from other government-run health programs? O’Dell: TrumpRx is different in that its ...
Swiss CDMO Lonza is making a move to strengthen and speed up quality control testing with the purchase of French rapid ...
The pharmaceutical world offers a valuable blueprint on how to harness AI’s efficiency while protecting trust, ethics and above all, people.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results